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Abstract. The dynamic vascular changes in the breast resulting from manipulation of both inspired end-tidal partial
pressure of oxygen and carbon dioxide were imaged using a 30 s per frame frequency-domain near-infrared spectral
(NIRS) tomography system. By analyzing the images from five subjects with asymptomatic mammography under
different inspired gas stimulation sequences, the mixture that maximized tissue vascular and oxygenation changes
was established. These results indicate maximum changes in deoxy-hemoglobin, oxygen saturation, and total
hemoglobin of 21, 9, and 3%, respectively. Using this inspired gas manipulation sequence, an individual case
study of a subject with locally advanced breast cancer undergoing neoadjuvant chemotherapy (NAC) was ana-
lyzed. Dynamic NIRS imaging was performed at different time points during treatment. The maximum tumor
dynamic changes in deoxy-hemoglobin increased from less than 7% at cycle 1, day 5 (C1, D5) to 17% at (C1, D28),
which indicated a complete response to NAC early during treatment and was subsequently confirmed pathologi-
cally at the time of surgery. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.18.7.076011]
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oxygen and carbon dioxide.
Paper 130204R received Apr. 4, 2013; revised manuscript received May 16, 2013; accepted for publication Jun. 11, 2013; published
online Jul. 10, 2013.
1 Introduction
Hypoxia is a characteristic of many locally advanced solid
tumors. Inadequate oxygen supply results from inefficient vas-
cular support during exponential cellular proliferation. Hypoxia
is an important factor in tumor growth and, consequently,
in determining responsiveness to antihypoxia-directed thera-
pies.1–3 The ability to assess variations in tumor oxygenation
from changes in arterial blood partial pressure of oxygen
(pO2) and carbon dioxide (pCO2) and to correlate these changes
to treatment response could identify patients who would benefit
from vasoactive interventions.4,5
The methods that have received the most attention for meas-
uring tumor hypoxia involve either oxygen electrodes or tissue
immunohistochemistry.6 However, both approaches are invasive
and difficult to apply in vivo.7 While human tumor hypoxia has
been successfully imaged with positron emission tomography,5
blood oxygen level-dependent magnetic resonance imaging,7
and near-infrared spectral (NIRS) tomography,8 its global effect
(which is a more important factor in cellular resistance to treat-
ment7) is less likely to be observed with static blood oxygena-
tion images as these results predominantly reflect perfusion-
related hypoxia (because of the distance between blood vessels
and hypoxic areas in tissue). Oxygenation changes in tumor dur-
ing hyperoxic and hypercarbic gas breathing have also been
imaged in animal models9,10 and humans.11–13 In these cases,
the inspired gas stimulates a change in intravascular oxygena-
tion, which enhances/modifies the diffusion of soluble oxygen
into tissue, eventually inducing greaterO2 uptake in tumors. The
approach represents more than just a passive hypoxia measure-
ment because it is a direct probe of the responsiveness, and
thereby aggressiveness, of the tumor. In previous studies, the
hyperoxic stimulus has been the administration of O2, which
causes hyperventilation, a reduction in arterial blood pCO2,
and vasoconstriction, counteracting the effects of the increases
in arterial blood pO2 on tissue. In addition, each subject has var-
ied response to an increase in inspired O2 concentration. This
intersubject variability limits the ability to specify tumor pO2
via inspired pO2 (Refs. 14 and 15).
Since increases in arterial blood pO2 and pCO2 cause
vasoconstriction and vasodilation in tumors, respectively,
interpretation of these dynamic responses would be signifi-
cantly improved if arterial blood pCO2 and pO2 were known.
Fortunately, these quantities can not only be tracked but they
can also be prospectively maintained with an automated com-
puter-controlled gas blender. While end-tidal pCO2, pO2, and
minute ventilation are commonly linked, this system applies
the method described by Slessarev et al.16 to target indepen-
dent values of inspired end-tidal pO2 and pCO2 gas and minute
ventilation. In this preliminary clinical study, the above gas
sequencer and breathing circuit have been used to prospectively
target and independently sustain end-tidal pO2 and pCO2 values
during an imaging session. We hypothesize that the response of
tumor vascular and cellular energetics to a transient challenge inAddress all correspondence to: Shudong Jiang, Dartmouth College, Thayer
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blood oxygen delivery is a direct measure of tumor aggressive-
ness and resistance to anticancer chemotherapies. We expect the
higher contrast of dynamic NIR property changes between the
tumor area and surrounding normal tissue will obtain better
tumor response to treatment early in the course of therapy, espe-
cially when acquired during blood gas manipulation through
control of inspired gas concentrations. To test this hypothesis,
a patient gas access interface was designed to be consistent
with breast imaging, and the dynamic vascular changes in breast
were imaged with a 30-s time resolution. By analyzing the
resulting images from five normal subjects breathing under
different gas stimulation patterns, the sequence that maximized
tissue vascular and oxygenation changes in the breast was deter-
mined. Representative results from one of the normal subject
cases shows that maximum changes in deoxy-hemoglobin (Hb),
oxygen saturation (StO2), and total hemoglobin (HbT ) of 21, 9,
and 3%, respectively, can be induced. Three breast cancer
patients undergoing neoadjuvant chemotherapy (NAC) were
also imaged during their course of treatment.
2 Methods and Material
2.1 Imaging System and Reconstruction
The basic design of the NIRS system used in this study for
simultaneously acquiring three wavelengths of frequency
domain data is described in detail elsewhere.17 Briefly, one
end of each of the 16 10-mm-diameter optical fiber bundles
is placed in a circular plane around the breast. The other
ends of these 16 fiber bundles are uniformly attached to a
circular rotating stage. One of the 16 fiber bundles is coupled
to a source fiber that delivers light from a laser source subsys-
tem, and each of the other 15 fiber bundles is coupled to indi-
vidual photomultiplier tubes (PMTs) for detecting the diffuse
light from 15 different positions around the breast. The laser
source subsystem incorporates three laser diodes and couples
wavelength and output power levels into the source fiber of
658 nm∕18 mW, 785 nm∕17 mW, and 826 nm∕24 mW, res-
pectively. The laser power at each wavelength is modulated
with frequencies of 100.0006, 100.0009, and 100.0013 MHz,
respectively, and the electrical outputs of each PMT are hetero-
dyned with a 100.0000 MHz signal to generate offset frequen-
cies of 600, 900, and 1300 Hz, accordingly. The total mixed
signal containing each of the three frequencies is sampled,
and the individual frequency components are extracted in soft-
ware with lock-in detection to yield their respective amplitudes
and phases. The process is repeated at each of the 16 source
positions for all 15 detectors by rotating the stage 360 deg,
such that 240 data points of amplitude and phase are acquired
at each wavelength, simultaneously. One complete measurement
at all source positions occurs in approximately 20 s.
A spectrally constrained chromophore and scattering
reconstruction method recovers images of the dynamic vascular
and oxygenation changes.18 Since we only acquire amplitude
and phase data at three wavelengths, the smaller dynamic
changes of water and scattering power, which may be present,
have been ignored.
2.2 Gas Administration and Stimulus Sequence
To manipulate arterial blood gases during a breast exam, a
custom gas sequencer and associated breathing circuits
(Respiract™, Thornhill Research, Toronto, Canada) were used.
The Respiract™ gas sequencer is designed to prospectively
target and sustain end-tidal pO2 and pCO2 independent of each
other. Baseline breathing data were obtained at the start of
an exam, and a computer calculated and controlled gas flow
from three cylinders with different O2 and CO2 concentrations
while a rebreathing circuit ensured that end-tidal pCO2 and pO2
attained their desired values within a few mmHg. In order to
integrate the gas sequencer into our breast imaging system,
the original facemask and head holder portion of the exam
table were modified.
Figure 1 show a typical stimulation sequence used to
manipulate the subject’s arterial blood gases. In this sequence,
targeted end-tidal values of pCO2 and pO2 were 38 and
100 mmHg for baseline, 45 and 400 mmHg for hypercarbia
and hyperoxia (or 45 and 100 mmHg for hypercarbia only),
and 38 and 500 mmHg for hyperoxia, respectively.
2.3 Preliminary Study Design
This preliminary study was carried out under a protocol, which
was approved by Dartmouth’s institutional review board. Five
normal subjects of different ages and radiographic breast
densities and three breast cancer patients undergoing NAC
were enrolled and imaged multiple times. All subjects were
questioned about their respiratory health, including specific
inquiries on their history of asthma, medications, chronic
obstructive pulmonary disease, and any current respiratory
issues, to ensure inclusion criteria were met without exclusions.
Subjects experiencing an exacerbation of a pre-existing respira-
tory condition and/or a current respiratory or lung problem,
which could place them at risk during periods of hypercarbia,
were excluded. Before proceeding to imaging, all subjects
who met inclusion/exclusion criteria were tested for tolerance
to the increase of pCO2 (up to 45 mmHg or a pCO2 increase
that was no greater than 15% above the subject’s baseline
end-tidal pCO2). One of the study subjects had withdrawn at
this testing stage because of her extremely low tolerance of
increased pCO2.
Figure 2 shows views of the imaging room in which the cus-
tom gas sequencer [Fig. 2(a)] and breathing circuit [Fig. 2(b)]
were used to manipulate the arterial blood gases of the subject.
The subject was positioned prone on the exam table [Fig. 2(c)]
with a face mask applied [Fig. 2(d)]. The elastic straps on the
mask are tightened to ensure a proper seal. End-tidal pCO2
and pO2 of the subject were prospectively targeted to follow
the inspired gas sequence shown in Fig. 1, and dynamic tissue
oxygen changes were imaged in the breast with 30-s time
resolution.
Fig. 1 A typical stimulation sequence. Targeted end-tidal values
of pCO2 and pO2 were 38 and 100 mmHg for baseline, 45 and
400 mmHg for hypercarbia and hyperoxia (or 45 and 100 mmHg for
hypercarbia only), and 38 and 500 mmHg for hyperoxia, respectively.
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3 Results
Figure 3 shows an example of end-tidal pCO2 (dashed line), pO2
(solid line), and breast StO2 (squares) of a normal subject during
(a) unregulated inhalation of medical air and (b) regulated inha-
lation of the gas from the Respiract™ gas sequencer. Without
regulation, StO2 in the breast fluctuates erratically but with little
overall variation on the order of 3% [Fig. 3(a)], whereas with
regulation, StO2 changes much more smoothly and extensively
with a 9% variation following a perturbation in pCO2 and pO2
[Fig. 3(b)].
Figure 4 shows an example of the dynamic changes in StO2,
Hb, and HbT that occur in the breast of a normal subject during
the gas manipulating sequence of hypercarbia and hyperoxia
followed by periods of hyperoxia. The subject is a 45-year-
old woman with mammographically scattered fibroglandular
density. Her annual mammographic images indicated that she
was free of breast disease. In Fig. 4, the left vertical axes
show NIRS properties (i.e., StO2, Hb, and HbT ), whereas the
right vertical axes represent one tenth of pO2 and pCO2.
Dashed and solid lines indicate the measured end-tidal pCO2
and pO2 values, and the squares, circles, and crosses show
the average StO2, Hb, and HbT data over the whole image
plane, over time. During the gas stimulus sequence, the NIRS
properties remained constant for the baseline period (pO2 ¼
100 mmHg; pCO2 ¼ 38 mmHg). As the arterial blood
pCO2 and pO2 values were increased to 45 and 400 mmHg
(hypercarbia and hyperoxia), respectively, StO2 increased while
Hb decreased significantly. The same trend continued during the
period following baseline when pCO2 and pO2 was further
increased to 500 mmHg (hyperoxia). During the last period
when pCO2 and pO2 both returned to baseline values, StO2
and Hb remained relatively constant as the hyperoxia period
Fig. 2 Views of the imaging room. (a) Console area for NIRS and gas supply control system (Respiract™). Exam table is located behind the window.
(b) The breathing circuit under the table next to the fiber optical interface. (c) A subject lying prone on the breast exam table. (d) A subject with facemask
before being positioned on the headrest.
Fig. 3 An example of end-tidal pCO2, pO2, and breast StO2 of a normal subject during (a) unregulated inhalation of medical air and (b) regulated
inhalation of gas with a step change in values at 4 and 10 min. Breast StO2 is determined from image data acquired by our dynamic near-infrared
spectral (NIRS) tomography system.
Fig. 4 Dynamic changes in (a) StO2, (b) Hb, and (c) HbT during a gas stimulus sequence consisting of 5 min of hypercarbia and hyperoxia
(pO2 ¼ 400 mmHg; pCO2 ¼ 45 mmHg) followed by periods of hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg). Left vertical axes represent
the NIRS properties, and right vertical axes show one tenth of pO2 and pCO2. Dashed and solid lines indicate measured end-tidal pCO2 and
pO2, and the squares, circles, and crosses show the imaged StO2, Hb, and HbT values over time.
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ended, but did not return to the values present during the base-
line period prior to pCO2 and pO2 increase. As expected, HbT
did undergo notable changes during the entire blood gas stimu-
lation process. Total changes in StO2, Hb, and HbT were 9, 21,
and <3%, with the variations over the entire image plane being
less than 0.7%, 0.2 μM, and 0.5 μM, respectively. These
results indicate that dynamic NIRS tomography may track
vascular and structural, as well as tissue oxygen, changes inde-
pendently by combining the dynamic responses of the NIRS
parameters.
To validate the stability of the gas stimulation and systemi-
cally test which mixtures cause the largest change in breast oxy-
genation, five normal subjects were imaged multiple times under
different gas sequences. Figure 5 shows dynamic Hb changes in
the breast of a subject during four different stimulus sequences.
The imaging sessions were carried out on different days over a
three-month period. For each exam session, the images were
acquired every 30 s during a total imaging time of 14 to
20 min. After 2 to 5 min of imaging under baseline condi-
tions (pO2 ¼ 100 mmHg; pCO2 ¼ 38 mmHg), (a) 4 min of
hypercarbia (pO2 ¼ 100 mmHg; pCO2 ¼ 45 mmHg) followed
by 5 min hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg);
(b) 5 min of hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼
38 mmHg) followed by 2 min baseline and 4 min of hyper-
carbia (pO2 ¼ 100 mmHg; pCO2 ¼ 45 mmHg); (c) 4 min
of hypoxia (pO2 ¼ 90 mmHg; pCO2 ¼ 38 mmHg) followed
by 5 min hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg);
and (d) 5 min hypercarbia and hyperoxia (pO2 ¼
400 mmHg; pCO2 ¼ 45 mmHg) followed by hyperoxia
(pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg) were set as target
goals for arterial blood pCO2 and pO2. All four of these
sequences were completed after targeting the baseline pCO2
and pO2 values for 2 to 5 min. During the baseline measurement
period, the normal breast Hb remained constant. Following the
end-tidal pCO2 and/or pO2 increases to highs of 45 and/or
500 mmHg, respectively, Hb decreased gradually with different
rates resulting from the different inspired gas manipulating
sequences. The total changes in Hb were 14, 13, 5, and
21%, respectively. These results are shown in Fig. 5(d),
which used the same sequence as in Fig. 4(b), but the exam
was carried out 105 days after the first session. The largest nor-
mal breast Hb change (21%) was induced by hypercarbia and
hyperoxia followed by periods of hyperoxia [Figs. 4(b) and 5(d)
versus Fig. 5(a) through 5(c)]. The variation between Hb curves
shown in Figs. 4(b) and 5(d) is less than 0.2%.
Three patients undergoing NAC for locally advanced breast
cancer were enrolled in this imaging study. One patient with-
drew in the first imaging session because of discomfort stem-
ming from the scent of the facemask. For another cancer
patient, the signal-to-noise ratio of the optical signal was not
sufficiently high for the imaging processing due to high breast
density and diameter (plane diameter is >120 mm). Figure 6
depicts representative NIRS images and dynamic changes in
a patient who ultimately showed a pathological complete
response (pCR) to therapy. This 44-year-old woman had two
invasive ductal carcinoma masses in the upper central portion
of her right breast at 11:00 and 1:00 o’clock en face with
sizes 1.6 × 1.2 × 1.2 and 1.8 × 1.4 × 1.7 cm, respectively. The
chemotherapy regimen consisted of four cycles paclitaxel/tras-
tuzumab which were given weekly for 16 weeks. Figure 6(a)
contains static NIRS images of the abnormal breast at three
time points during treatment. Arrows in HbT images indicate
Fig. 5 Dynamic Hb changes in a breast during four different gas sequences. After 2 to 5 min of baseline (pO2 ¼ 100 mmHg; pCO2 ¼ 38 mmHg)
imaging, (a) 4 min of hypercarbia (pO2 ¼ 100 mmHg; pCO2 ¼ 45 mmHg) followed by 5 min of hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg);
(b) 5 min of hyperoxia (pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg) followed by 2 min of baseline and 4 min of hypercarbia (pO2 ¼ 100 mmHg;
pCO2 ¼ 45 mmHg); (c) 4 min of hypoxia (pO2 ¼ 90 mmHg; pCO2 ¼ 38 mmHg) followed by 5 min of hyperoxia (pO2 ¼ 500 mmHg;
pCO2 ¼ 38 mmHg); and (d) 5 min of hypercarbia and hyperoxia (pO2 ¼ 400 mmHg; pCO2 ¼ 45 mmHg) followed by period of hyperoxia
(pO2 ¼ 500 mmHg; pCO2 ¼ 38 mmHg). Left vertical axes show Hb while right vertical axes represent one tenth of pO2 and pCO2. Dashed and
solid lines correspond to end-tidal pCO2 and pO2 values, and the circles are the imaged Hb values at different times.
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the tumors. The tumor was visible in the HbT concentration
image at cycle 1, day 5 (C1, D5), almost disappeared at (C1,
D28), and was not observable after NAC. No significant change
in tumor area was observed in either StO2 or Hb images during
NAC. Figure 6(b) shows the dynamic StO2 (left), Hb (middle),
and HbT (right) changes quantified in the known tumor regions
at the 11:00 (red triangles) and 1:00 (pink squares) clock-face
positions relative to surrounding normal tissue (dark blue
crosses), at (C1, D5) (top), (C1, D28) (middle), and post NAC
(bottom). The size and the location of the region of interest were
defined according to the radiologist assessment of the magnetic
resonance images taken before beginning the treatment. Dashed
and solid lines show the directly measured pCO2 and pO2 val-
ues. Similar to the results shown in the normal breast [Fig. 4(c)],
HbT in the tumor regions does not present clear changes follow-
ing pO2 and pCO2 alterations in the patient’s inspired air.
However, the absolute values of HbT in the tumor regions
were reduced after the first NAC infusion and reached levels
similar to the normal surrounding tissue by the end of treatment.
Additionally, Hb in the tumor regions did not follow the blood
gas changes at (C1, D5). However, it started to follow the arterial
blood gas manipulations at (C1, D28) and a trend similar to that
Fig. 6 Representative NIRS images and dynamic changes in a pCR patient undergoing NAC. Arrows in HbT images indicate the tumors. (a) Static NIRS
images of the abnormal breast at three time points during treatment. (b) Dynamic StO2 (left), Hb (middle), and HbT (right) changes in tumors at 11:00
(red triangles) and 1:00 (pink squares) o’clock en face and the surrounding normal tissue (dark blue crosses) at (C1, D5) (top), (C1, D28) (middle), and
post-treatment (bottom). Dashed and solid lines show measured pCO2 and pO2 values inferred from the measured expired-air gas concentrations.
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shown in Figs. 4 and 5 was observed after the completion of
NAC. Compared to the absolute values of StO2 in the surround-
ing normal tissue estimated from the images obtained at (C1,
D5), StO2 in one tumor region was higher (pink squares) but
was lower (red triangles) in the other tumor region.
Nonetheless, StO2 in both tumor regions followed trends similar
to that in pO2 and pCO2 changes found in the normal breast
[Fig. 4(a)]. Indeed, the relative changes from the inspired gas
manipulation increased gradually toward the end of the treat-
ment. The variations of StO2, Hb, and HbT over the region
of interest were less than 1.4%, 0.3 μM, and 0.7 μM,
respectively. The maximum tumor dynamic changes in Hb
increased from less than 7% at (C1, D5) to 17% at (C1,
D28) and eventually reached 24% after treatment. The postsur-
gical pathology confirmed a complete pathological response.
4 Discussion
The static NIRS StO2 images in Fig. 6(a) were insensitive to
prepost treatment effects, but may not reflect tumor hypoxia
because the vascular supply may be too distant from areas of
hypoxia.7 To overcome this limitation, we developed a dynamic
NIRS tomography system to image the breast during changes in
inspired gas concentrations to amplify the effects caused by tis-
sue vascular supply. Since increases in arterial blood pO2 and
pCO2 cause vasoconstriction and vasodilation in tumors, respec-
tively, interpretation of these dynamic responses would be sig-
nificantly improved if arterial blood pCO2 and pO2 were known.
Fortunately, these quantities can not only be tracked but also be
prospectively maintained with an automated computer-con-
trolled gas blender. While end-tidal pCO2, pO2, and minute ven-
tilation are commonly linked, this system applies the method
described by Slessarev et al.16 to target independent values of
inspired end-tidal pO2 and pCO2 gas and minute ventilation.
As opposed to otherwise administering inhaled gas mixtures
(where a poor relationship exists between the exhaled gas con-
centrations and those in the blood),11–15 end-tidal (i.e., exhaled
gas) partial pressures were controlled, and these quantities have
been shown to be surrogates for those in the arterial blood
(allowing the arterial blood partial pressure to be monitored
and controlled during NIRS imaging for the first time). The
results in Figs. 3 through 6 indicate that manipulating the arterial
blood pO2 and pCO2 independently is likely to optimize the tis-
sue oxygenation measured by NIRS. In addition, the variations
of only 0.2% in the Hb changes that occurred during two exams,
which were conducted on different days [Figs. 4(b) and 5(d)],
suggests that the approach used in this study has significant
potential to provide the stable arterial blood gas manipulation
necessary for achieving repeatable, dynamic tissue oxygenation
imaging.
Theoretically, StO2 and Hb should return to their baseline
values after pCO2 and pO2 are similarly returned to baseline.
However, in the results shown in Figs. 3 through 6, StO2 and
Hb are kept constant either at the highest (StO2) or lowest
(Hb) values during the last recovering period. This trend was
observed during every gas manipulating sequence for each sub-
ject. To validate that the changes in StO2 and Hb were due to
arterial blood gas manipulations, the baseline images acquired
under baseline pO2 and pCO2 were recorded for 20 min after the
last gas sequence was completed in the normal subjects. The
baseline StO2 and Hb from these later images indicate that
the data variation at the end of the imaging exam was caused
by the very slow recovery process after arterial blood gas
manipulation. Although we observed this trend in all our normal
and cancer subjects, the reason is still unclear physiologically. It
may due to the compensation of the vasoconstriction and vaso-
dilation in breast or tumor, but at this early pilot phase, it is hard
to discern mechanisms underlying this subtle change in base-
line. Nonetheless, the changes in StO2 and Hb during the
first three gas manipulation periods provide important informa-
tion on the dynamics of blood supply in response to subject-con-
trolled arterial blood gas changes. In future studies, reductions in
imaging time will allow us to eliminate the final recovery period.
In Fig. 4, as expected, HbT did not change significantly dur-
ing the arterial blood gas manipulation because blood vessel
vasoconstriction and vasodilation mainly influence blood oxy-
genation but not blood volume. This result may indicate that the
arterial blood gas manipulation approach can more clearly link
tumor response to antihypoxia-directed therapies than static
NIRS imaging methods, because it can separate tumor hypoxia
from blood volume change. Originally, we expected to obtain a
larger StO2 change during arterial blood gas manipulation.
However, larger percentage Hb changes have been observed
in both normal (Fig. 4) and cancerous [Fig. 6(b)] breasts.
Considering the results we obtained in our previous study
without feedback control of the inspired gas mixture based
on end-tidal measurements,11,14 this outcome may be due to
StO2 changes involving both Hb and HbO, but with some
phase delay between the Hb and HbO alterations.
In Fig. 6(b), changes in Hb in both tumor regions resulting
from arterial blood gas manipulation gradually increased during
NAC and reached ∼24% after NAC in the pCR case presented,
which may be due to the decreasing ability of tumor vessels to
vasoconstrict and vasodilate compared with their counterparts in
the normal breast. Consider that the absolute StO2 and Hb val-
ues in the two tumor regions presented different trends relative
to the surrounding normal tissue at (C1, D5) and at (C1, D28);
yet, both tumors were found to have pathological complete
responses after NAC, the percent change in StO2 and Hb
under arterial blood gas manipulation may be the better predi-
cators of tumor response to NAC.
5 Conclusion
Based on blood vessel vasoconstriction and vasodilation
expected in tumors from increases in arterial blood pO2 and
pCO2, tumor imaging during manipulation of both arterial
blood pCO2 and pO2 would allow a direct assessment of
tumor aggressiveness and resistance to NAC. In this pilot series
of clinical exams, dynamic NIRS imaging was performed in
the normal breast and the cancer-bearing breast undergoing
NAC, during consistent stimulation created by controlling the
subject’s inspired gas concentration based on monitoring the
expired gas concentrations. A specialized sequencer and breath-
ing circuit were applied to target prospectively and sustain inde-
pendently end-tidal pO2 and pCO2. Dynamic vascular changes
in the breast were imaged by a frequency-domain NIRS tomo-
graphic system with 30-s time resolution. By analyzing the
resulting images from subjects with asymptomatic mammogra-
phy under different arterial blood pCO2 and pO2 manipulation
sequences, the best sequences for maximizing tissue vascular
and oxygenation changes were found. Results from a particular
normal subject show maximum changes in Hb, StO2, and HbT
of 21, 9, and 3%, respectively. By using the same manipulation
sequence, three cancer patients undergoing NAC have been
imaged at different time points during the course of treatment.
Journal of Biomedical Optics 076011-6 July 2013 • Vol. 18(7)
Jiang et al.: Pilot study assessment of dynamic vascular changes in breast cancer. . .
In a representative case of a complete responder, the induced
changes indicative of response in Hb, StO2, and HbT of two
invasive ductal carcinoma masses in the same breast were
observed early during treatment.
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